Pharmaceuticals

Anti-Neoplastic Agents Market to Grow at a CAGR of 8.8% from 2025 to 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Anti-Neoplastic Agents Market Covering 2025–2034?

The anti-neoplastic agents market has demonstrated significant growth in recent years. It is projected to expand from $130.01 billion in 2024 to $140.9 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.4%. This historical expansion can be attributed to increasing cancer incidence, a growing demand for therapies, a rising preference for minimally invasive cancer treatments, and the need for affordable anti-neoplastic treatments.

The market for anti-neoplastic agents is projected to experience substantial expansion over the upcoming years. By 2029, this market is anticipated to reach $197.68 billion, advancing at a compound annual growth rate (CAGR) of 8.8%. This expansion during the projection period stems from factors such as enhanced patient education and awareness, government initiatives, an increasing need for individualized cancer therapies, and a heightened emphasis on improving the quality of life for cancer patients. Key developments anticipated during this timeframe involve progress in oncology research, the creation of targeted therapeutic approaches, breakthroughs in biotechnology, and improvements in diagnostic tools.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12901&type=smp

Which Major Market Drivers Are Shaping The Future Of The Anti-Neoplastic Agents Market?

The expanding prevalence of cancer cases is set to propel the growth of the antineoplastic agent market moving forward. Cancer is defined as a group of diseases where abnormal cells multiply without control in almost any organ or tissue, extending beyond their normal boundaries and potentially invading adjacent body parts or spreading to other organs. Antineoplastic agents are vital in cancer therapy, working to impede cancer cell growth and division via various methods, including causing DNA (Deoxyribonucleic acid) damage, disrupting the cell cycle, and interfering with essential cellular pathways. For example, in February 2024, recent estimates from the International Agency for Research on Cancer (IARC), a France-based international agency fostering global collaboration in cancer research, project that the global cancer burden will increase to over 35 million by 2050, marking a 77% surge from the estimated 20 million in 2022. This increasing count of cancer cases is thus a primary driver for the expansion of the antineoplastic agent market.

What Are The Major Segment Categories Driving The Anti-Neoplastic Agents Market Growth?

The anti-neoplastic agents market covered in this report is segmented –

1) By Type: Alkylating Agents, Antimetabolites, Hormones And Antagonists, Miscellaneous

2) By Disease Type: Gastrointestinal Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Other Disease Types

3) By End User: Hospitals, Clinics, Cancer Rehabilitation Centers, Ambulatory Surgical Centers

Subsegments:

1) By Alkylating Agents: Nitrogen Mustards, Alkyl Sulfonates, Nitrosoureas, Triazines

2) By Antimetabolites: Purine Analogues, Pyrimidine Analogues, Folate Antagonists

3) By Hormones and Antagonists: Estrogens and Antiestrogens, Androgens and Antiandrogens, Glucocorticoids

4) By Miscellaneous: Vinca Alkaloids, Taxanes, Antibiotic Antineoplastics, Targeted Therapy Agents

Which Key Trends Are Expected To Influence The Anti-Neoplastic Agents Market In The Coming Years?

Leading companies in the anti-neoplastic agent market are concentrating on developing clinical practices to maintain their standing. For instance, in March 2022, Novartis AG, a pharmaceutical corporation based in Switzerland, announced that the Food and Drug Administration’s (FDA) had approved Pluvicto. This therapy is the first targeted radioligand treatment for progressive, PSMA (Prostate-specific membrane antigen) positive metastatic castration-resistant prostate cancer (mCRPC). It is advised to administer 7.4 GBq (200 mCi) of Pluvicto intravenously every six weeks, for a maximum of six doses, or until disease progression or intolerable toxicity, whichever occurs first. Patients with previously treated mCRPC should be selected for Pluvicto treatment based on PSMA expression in their tumors, utilizing Locametz or another authorized PSMA-11 imaging agent.

Who Are The Major Companies Operating In The Anti-Neoplastic Agents Market?

Major companies operating in the anti-neoplastic agents market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Fresenius SE & Co. KGaA, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Ipsen SA, Cipla Limited, Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Limited, Hikma Pharmaceuticals PLC, Gland Pharma Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Jubilant Life Sciences Ltd., Lantheus Holdings Inc., Hutchison Medipharma Ltd., Natco Pharma Ltd., Accord Healthcare Limited, Qilu Pharmaceutical Co. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/anti-neoplastic-agents-global-market-report

How Does The Anti-Neoplastic Agents Market Perform Across Key Geographic Regions?

North America was the largest region in the anti-neoplastic agents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in anti-neoplastic agents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Anti-Neoplastic Agents Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12901&type=smp

Browse Through More Reports Similar to the Global Anti-Neoplastic Agents Market 2025, By The Business Research Company

Tissue Microarray Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

Soft Tissue Sarcoma Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/soft-tissue-sarcoma-global-market-report

Tissue Engineering Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tissue-engineering-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795